News

Filter

Current filters:

SandozImmunologicals

Sandoz launches Phase III trial of biosimilars of AbbVie’s Humira

Sandoz launches Phase III trial of biosimilars of AbbVie’s Humira

19-12-2013

Sandoz, the generics unit of Swiss drug major Novartis (NOVN: VX), has initiated a Phase III clinical…

AbbVieBiosimilarsHumiraImmunologicalsNorthern EuropeResearchSandoz

Novartis expands transplant portfolio with first branded generic tacrolimus

04-04-2012

Swiss drug major Novartis has announced the US introduction and availability of Hecoria (tacrolimus)…

Astellas PharmaGenericsHecoriaImmunologicalsMarkets & MarketingNorth AmericaNovartisPrografSandoztacrolimus

US court rejects Astellas’ appeal on generic immunosuppressants

14-09-2009

The US District Court in Washington DC has denied the Temporary Restraining Order and Preliminary Injunction…

Asia-PacificGenericsImmunologicalsNorth AmericaNovartisNystatinOralPrografProtopicSandoztacrolimus

Astellas Announces the Outcome of its Citizen Petition in the USA

11-08-2009

Japan’s Astellas Pharma says that its North American affiliate has received notice that the US.…

Asia-PacificAstellas PharmaImmunologicalsNorth AmericaNovartisNystatinOralPharmaceuticalPrografProtopicSandoztacrolimus

COMPANY SPOTLIGHT

Menarini

Back to top